Experienced in Polymorphous Light Eruption

Dr. Jennifer L. Parish

Dermatology
Lawrence Charles Parish MD
1845 Walnut St, Suite 1650, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Polymorphous Light Eruption
Lawrence Charles Parish MD
1845 Walnut St, Suite 1650, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jennifer Parish is a Dermatologist in Philadelphia, Pennsylvania. Dr. Parish is rated as an Experienced provider by MediFind in the treatment of Polymorphous Light Eruption. Her top areas of expertise are Jock Itch, Athlete's Foot, Perioral Dermatitis, and Sunburn.

Her clinical research consists of co-authoring 23 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

LAWRENCE CHARLES PARISH MD
1845 Walnut St, Suite 1650, Philadelphia, PA 19103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation
A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation
Enrollment Status: Recruiting
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 4
Phase 2a Prospective, Randomized, Double-blind, Intra-subject, Placebo-controlled, Proof of Concept Study to Evaluate the Efficacy of OLX10010 as an Adjunct Therapy to Reduce the Recurrence of Hypertrophic Scars After Scar Revision Surgery
Phase 2a Prospective, Randomized, Double-blind, Intra-subject, Placebo-controlled, Proof of Concept Study to Evaluate the Efficacy of OLX10010 as an Adjunct Therapy to Reduce the Recurrence of Hypertrophic Scars After Scar Revision Surgery
Enrollment Status: Completed
Publish Date: February 21, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
Enrollment Status: Unknown
Publish Date: April 04, 2022
Intervention Type: Biological, Other
Study Drug: FB825
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: January 12, 2022
Intervention Type: Drug
Study Drug: ASLAN004
Study Phase: Phase 1
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: June 23, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
Enrollment Status: Completed
Publish Date: May 21, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

23 Total Publications

Bibliography of secondary sources on the history of dermatology: I. Journal articles in English.
Bibliography of secondary sources on the history of dermatology: I. Journal articles in English.
Journal: Clinics in dermatology
Published: December 18, 2021
Similar Doctors
Advanced in Polymorphous Light Eruption
Dr. Sylvia Hsu
Dermatology
Advanced in Polymorphous Light Eruption
Dr. Sylvia Hsu
Dermatology

Temple Faculty Practice Plan Inc

1316 W Ontario St, 
Philadelphia, PA 
 (3.9 miles away)
215-707-8496
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sylvia Hsu is a Dermatologist in Philadelphia, Pennsylvania. Dr. Hsu is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Light Eruption. Her top areas of expertise are Psoriasis, Tinea Versicolor, Pustular Psoriasis, Atopic Dermatitis, and Leg or Foot Amputation.

Advanced in Polymorphous Light Eruption
Dr. Adam B. Woldow
Dermatology
Advanced in Polymorphous Light Eruption
Dr. Adam B. Woldow
Dermatology

Certified Dermatology PC

853 2nd St Pike, Suite A1, 
Richboro, PA 
 (19.8 miles away)
215-485-5713
Languages Spoken:
English
See accepted insurances

Adam Woldow is a Dermatologist in Richboro, Pennsylvania. Dr. Woldow is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Light Eruption. His top areas of expertise are Contact Dermatitis, Liver Spots, Universal Acquired Melanosis, and Plaque Psoriasis.

Advanced in Polymorphous Light Eruption
Dr. Carrie A. Cusack
Dermatology
Advanced in Polymorphous Light Eruption
Dr. Carrie A. Cusack
Dermatology

Dermatology Associates Of South Jersey, L.L.C.

150 Century Pkwy, Suite 105, 
Mount Laurel, NJ 
 (11.2 miles away)
856-206-0201
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carrie Cusack is a Dermatologist in Mount Laurel, New Jersey. Dr. Cusack is rated as an Advanced provider by MediFind in the treatment of Polymorphous Light Eruption. Her top areas of expertise are Actinic Keratosis, Warts, Seborrheic Keratosis, and Sunburn. Dr. Cusack is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parish's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile